T-cell-directed_JJ
TAL-1_NN
expression_NN
induces_VBZ
T-cell_NN
malignancies_NNS
in_IN
transgenic_JJ
mice_NNS
._.

The_DT
TAL-1_NN
gene_NN
specifies_VBZ
for_IN
a_DT
basic_JJ
domain-helix-loop-helix_JJ
protein_NN
,_,
which_WDT
is_VBZ
involved_VBN
in_IN
the_DT
control_NN
of_IN
normal_JJ
hematopoiesis_NN
._.

In_IN
human_JJ
pathology_NN
,_,
the_DT
TAL-1_NN
gene_NN
product_NN
is_VBZ
expressed_VBN
in_IN
a_DT
high_JJ
percentage_NN
of_IN
T-cell_NN
acute_JJ
lymphoblastic_JJ
leukemias_NNS
in_IN
the_DT
pediatric_JJ
age_NN
range_NN
;_:
however_RB
,_,
it_PRP
has_VBZ
not_RB
been_VBN
established_VBN
whether_IN
the_DT
expression_NN
has_VBZ
a_DT
causal_JJ
role_NN
in_IN
oncogenesis_NN
._.

In_IN
this_DT
report_NN
,_,
we_PRP
describe_VBP
the_DT
phenotype_NN
of_IN
mouse_NN
transgenic_JJ
lines_NNS
obtained_VBN
by_IN
inducing_VBG
tal-1_NN
protein_NN
expression_NN
in_IN
lymphoid_JJ
tissues_NNS
using_VBG
the_DT
LCK_NN
promoter_NN
._.

The_DT
survival_NN
rate_NN
of_IN
tal-1_NN
transgenic_JJ
animals_NNS
was_VBD
much_RB
lower_JJR
as_IN
compared_VBN
with_IN
control_NN
mice_NNS
._.

Histopathological_JJ
analysis_NN
revealed_VBD
lymphomas_NNS
of_IN
T-cell_NN
type_NN
,_,
often_RB
comprising_VBG
a_DT
minor_JJ
B-cell_NN
component_NN
._.

Some_DT
mice_NNS
showed_VBD
marked_JJ
splenic_JJ
lymphocyte_NN
depletion_NN
._.

Primary_JJ
lymphocyte_NN
cultures_NNS
showed_VBD
partial_JJ
independence_NN
from_IN
exogenous_JJ
growth_NN
stimuli_NNS
and_CC
increased_VBD
resistance_NN
to_TO
low-serum_JJ
apoptosis_NN
._.

To_TO
further_RB
unravel_VB
the_DT
tal-1_NN
oncogenic_JJ
potential_NN
,_,
a_DT
strain_NN
of_IN
tal-1_NN
transgenic_JJ
mice_NNS
was_VBD
crossbred_VBN
with_IN
p53_NN
-_:
\/_NN
-_:
mice_NNS
;_:
the_DT
survival_NN
rate_NN
in_IN
these_DT
animals_NNS
was_VBD
reduced_VBN
by_IN
more_JJR
than_IN
one-half_NN
when_WRB
compared_VBN
with_IN
that_DT
of_IN
tal-1_NN
mice_NNS
,_,
and_CC
histopathological_JJ
analysis_NN
revealed_VBD
exclusively_RB
T-cell_NN
lymphomas_NNS
._.

These_DT
data_NNS
indicate_VBP
that_IN
TAL-1_NN
,_,
expressed_VBN
in_IN
T_NN
cells_NNS
,_,
is_VBZ
per_FW
se_FW
a_DT
potent_JJ
oncogene_NN
,_,
which_WDT
may_MD
exert_VB
a_DT
key_JJ
leukemogenetic_JJ
role_NN
in_IN
the_DT
majority_NN
of_IN
T-cell_NN
acute_JJ
lymphoblastic_JJ
leukemias_NNS
._.

